Section Arrow
ZBH.NYSE
- Zimmer Biomet Holdings
Quotes are at least 15-min delayed:2025/10/28 19:16 EDT
After Hours
Last
 101
-0.14 (-0.14%)
Bid
98
Ask
108
High 103.16 
Low 99.96 
Volume 22196 
Regular Hours
Last
 101.14
-1.98 (-1.92%)
Day High 
103.15 
Prev. Close
103.12 
1-M High
106.88 
Volume 
956.51K 
Bid
98
Ask
108
Day Low
100.955 
Open
103.15 
1-M Low
94.01 
Market Cap 
20.43B 
Currency USD 
P/E 25.15 
%Yield 0.95 
10-SMA 101.83 
20-SMA 99.95 
50-SMA 101.8 
52-W High 114.72 
52-W Low 89.22 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
4.10/8.62
Enterprise Value
25.77B
Balance Sheet
Book Value Per Share
63.23
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
7.68B
Operating Revenue Per Share
36.75
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
LUNGPulmonx Corp1.98+0.42+26.92%-- 
After Hours 1.9299 -0.0501 -2.53%
CODXCo-Diagnostics0.57-0.69-54.76%-- 
After Hours 0.5418 -0.0282 -4.95%
SSKNStrata Skin Sciences1.93+0.25+14.88%-- 
After Hours 2.52 +0.59 +30.57%
PFSAProfusa Inc0.29-0.0061-2.06%-- 
After Hours 0.347 +0.057 +19.66%
EWEdwards Lifesciences Corp82.19+1.37+1.70%33.82PE
After Hours 81.3462 -0.8438 -1.03%
Quotes are at least 15-min delayed:2025/10/28 19:16 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.